Literature DB >> 27496930

STOPP/START version 2-development of software applications: easier said than done?

Pauline Anrys1, Benoît Boland2, Jean-Marie Degryse3, Jan De Lepeleire4, Mirko Petrovic5, Sophie Marien1, Olivia Dalleur6, Goedele Strauven7, Veerle Foulon8, Anne Spinewine9.   

Abstract

Explicit criteria, such as the STOPP/START criteria, are increasingly used both in clinical practice and in research to identify potentially inappropriate prescribing in older people. In an article on the STOPP/START criteria version 2, O'Mahony et al have pointed out the advantages of developing computerised criteria. Both clinical decision support systems to support healthcare professionals and software applications to automatically detect inappropriate prescribing in research studies can be developed. In the process of developing such tools, difficulties may occur. In the context of a research study, we have developed an algorithm to automatically apply STOPP/START criteria version 2 to our research database. We comment in this paper on different kinds of difficulties encountered and make suggestions that could be taken into account when developing the next version of the criteria.
© The Author 2016. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  STOPP/START criteria; clinical decision support systems; older people, inappropriate prescribing

Mesh:

Year:  2016        PMID: 27496930     DOI: 10.1093/ageing/afw114

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  7 in total

1.  Medication review and reconciliation in older adults.

Authors:  Jean-Baptiste Beuscart; Sylvia Pelayo; Laurine Robert; Stefanie Thevelin; Sophie Marien; Olivia Dalleur
Journal:  Eur Geriatr Med       Date:  2021-02-13       Impact factor: 1.710

2.  Assessment of the Appropriateness of Prescriptions in a Geriatric Outpatient Clinic

Authors:  Burcu Kelleci Çakır; Muhammet Cemal Kızılarslanoğlu; Mustafa Kemal Kılıç; Rana Tuna Doğrul; Mehmet Emin Kuyumcu; Aygin Bayraktar Ekincioğlu; Merve Başol; Meltem Halil; Kutay Demirkan
Journal:  Turk J Pharm Sci       Date:  2022-02-28

3.  Prevalence of potentially inappropriate prescribing in a subpopulation of older European clinical trial participants: a cross-sectional study.

Authors:  David O Riordan; Carole Elodie Aubert; Kieran A Walsh; Anette Van Dorland; Nicolas Rodondi; Robert S Du Puy; Rosalinde K E Poortvliet; Jacobijn Gussekloo; Carol Sinnott; Stephen Byrne; Rose Galvin; J Wouter Jukema; Simon P Mooijaart; Christine Baumgartner; Vera McCarthy; Elaine K Walsh; Tinh-Hai Collet; Olaf M Dekkers; Manuel R Blum; Patricia M Kearney
Journal:  BMJ Open       Date:  2018-03-22       Impact factor: 2.692

4.  Evaluation of clarity of the STOPP/START criteria for clinical applicability in prescribing for older people: a quality appraisal study.

Authors:  Bastiaan Theodoor Gerard Marie Sallevelt; Corlina Johanna Alida Huibers; Wilma Knol; Eugene van Puijenbroek; Toine Egberts; Ingeborg Wilting
Journal:  BMJ Open       Date:  2020-02-18       Impact factor: 2.692

Review 5.  Towards appropriate polypharmacy in older cardiovascular patients: How many medications do I have to take?

Authors:  Magali P A Disdier Moulder; Abby K Hendricks; Narith N Ou
Journal:  Clin Cardiol       Date:  2019-12-11       Impact factor: 2.882

6.  Use of an Electronic Clinical Decision Support System in Primary Care to Assess Inappropriate Polypharmacy in Young Seniors With Multimorbidity: Observational, Descriptive, Cross-Sectional Study.

Authors:  Eloisa Rogero-Blanco; Juan A Lopez-Rodriguez; Teresa Sanz-Cuesta; Mercedes Aza-Pascual-Salcedo; M Jose Bujalance-Zafra; Isabel Cura-Gonzalez
Journal:  JMIR Med Inform       Date:  2020-03-03

7.  Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity.

Authors:  Bastiaan T G M Sallevelt; Corlina J A Huibers; Jody M J Op Heij; Toine C G Egberts; Eugène P van Puijenbroek; Zhengru Shen; Marco R Spruit; Katharina Tabea Jungo; Nicolas Rodondi; Olivia Dalleur; Anne Spinewine; Emma Jennings; Denis O'Mahony; Ingeborg Wilting; Wilma Knol
Journal:  Drugs Aging       Date:  2021-12-08       Impact factor: 3.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.